When it was launched, NUTRAGENOM’s focus was analyzing clients’ DNA for the amelioration of nutritional deficiencies due to genetic variants. The discovery of a new biotechnology—H2B—transformed its mission. Knowing that we could capture and sustain large volumes of molecular hydrogen, we recognized that we could make an important contribution to physicians and patients, while extending the benefits of our technology to address urgent problems of food production.
Today, we are working with our strategic partners to launch our first flagship product, H2-Satiety Gel, an important innovation in the field of appetite control and weight loss.
We are also highly focused on developing the next generation of health-related products based on the H2B biotechnology. Once these are in production, we will turn our attention to seeking partners in drug delivery, medical imaging and food production.
We welcome enquiries from potential collaborators in these exciting ventures. If you would like to discuss participation in NUTRAGENOM’s development, please contact us here: